CliniGA CRO

CliniGA CRO Blog

CTMS Scope: Separate Tracking from Authoritative Records

A CTMS can coordinate milestones, visits and issues, but unreliable ownership turns it into a second version of every spreadsheet. Define which decisions.

Cover image for: CTMS Scope: Separate Tracking from Authoritative Records
Photo: Nenad Stojkovic · License: CC BY 2.0 · Cropped and resized.
Published
Updated
Sources checked

A CTMS can coordinate milestones, visits and issues, but unreliable ownership turns it into a second version of every spreadsheet. Define which decisions the system supports before configuring fields and reports.

Assign field ownership

Build a field ownership table for site activation, participant counts, monitoring visits and payments. Identify the authoritative source for each value and the person allowed to correct it. Avoid treating a manually entered milestone as proof that the underlying activity is complete.

Separate forecast and actual dates

For example, a site activation date can link to an approved release checklist rather than merely a planned date. Preserve the difference between forecast, actual completion and sponsor acceptance so portfolio reporting does not erase operational uncertainty.

CTMS configuration checks

  • Define milestone meanings and allowed status transitions.
  • Reconcile imported counts with the named source and extraction date.
  • Assign review responsibility for stale forecasts and duplicate sites.

Pilot one complete site workflow

Pilot one site through activation and a monitoring visit. Accept the configuration when the dashboard, source records and issue log tell the same story. Retain unresolved mapping decisions in a controlled backlog before wider rollout. Before assessing site performance, distinguish a genuine activation blocker from a completed activity whose CTMS field has simply not been updated.

Frequently asked questions

Can the CTMS replace the eTMF?
Only where its intended record functions and controls have been assessed; tracking alone does not establish that capability.
Who owns imported data?
Name a business owner for interpretation and a technical owner for transfer failures.

Sources

  1. EMA — Computerised systems and electronic data in clinical trials
  2. FDA — Electronic systems, records and signatures, October 2024